The gene expression of DCK was significantly lower in t(17;19)‐ALL cell lines consistent with their Ara‐C resistance, but not in Ph+ALL and MLL+ALL cell lines despite their Ara‐C resistance. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.